• Hydrogel coils improve outcomes in medium-sized intracranial aneurysms

    on February 24th, 2017
    AT THE INTERNATIONAL STROKE CONFERENCE HOUSTON (FRONTLINE MEDICAL NEWS) – Hydrogel coils significantly outperformed bare platinum coils in treating patients with medium-sized intracranial aneurysms, reducing the incidence of adverse outcomes by about 9% in an open-label, randomized trial. Compared[...]
  • Anticoagulant resumption after ICH aids patients

    on February 24th, 2017
    AT THE INTERNATIONAL STROKE CONFERENCE HOUSTON (FRONTLINE MEDICAL NEWS) – Even when patients on an oral anticoagulant have the dreaded complication of an intracerebral hemorrhage, resumption of their oral anticoagulation regimen appears to produce the best midterm outcomes, based on a meta-analysi[...]
  • Spotlight shifts to active treatment for concussions

    on February 23rd, 2017
    The prevailing notion that concussions should be managed solely or primarily with prescribed cognitive and physical rest is shifting. Experts in concussion management are increasingly in agreement that concussion is a much more heterogeneous injury than previously believed, and that “active” app[...]
  • Exercise can boost cognition after stroke

    on February 23rd, 2017
    AT THE INTERNATIONAL STROKE CONFERENCE HOUSTON (FRONTLINE MEDICAL NEWS) – Exercise seems to improve some of the cognitive difficulties that can manifest in stroke survivors, even if patients don’t hit the gym for a couple of years after the incident. A meta-analysis of 14 randomized, controlled [...]
  • Mesh cylinder effective for small to medium wide-necked aneurysms

    on February 22nd, 2017
    AT THE INTERNATIONAL STROKE CONFERENCE HOUSTON (FRONTLINE MEDICAL NEWS) – An expandable mesh cylinder that is approved to treat large, wide-necked carotid aneurysms has now proved successful in treating small lesions of the internal carotid or vertebral artery up to 12 mm in diameter. The Pipeline[...]
  • Testosterone Trials’ cardiac, cognitive results disappoint

    on February 22nd, 2017
    FROM JAMA AND JAMA INTERNAL MEDICINE Testosterone treatment may have beneficial effects on unexplained anemia or bone density in men with age-related low testosterone, but at the cost of an increase in coronary artery plaque and with no benefit on cognitive function, new research suggests. The resul[...]
  • Light therapy eases Parkinson’s-related sleep disturbances

    on February 21st, 2017
    FROM JAMA NEUROLOGY Light therapy significantly reduced excessive daytime sleepiness, improved sleep quality, decreased overnight awakenings, shortened sleep latency, enhanced daytime alertness and activity level, and improved motor symptoms in patients with Parkinson’s disease, according to a rep[...]
  • Outpatient visits for CNS polypharmacy rising among elderly

    on February 13th, 2017
    FROM JAMA INTERNAL MEDICINE The number of outpatient visits for CNS polypharmacy by adults aged 65 and older more than doubled between 2004 and 2013, especially among those who reside in rural areas, results from a large analysis of national data showed. “With each new revision of the Beers Criter[...]
  • Guideline: Prioritize nondrug therapies for low back pain

    on February 13th, 2017
    FROM ANNALS OF INTERNAL MEDICINE Clinicians and patients should prioritize nonpharmacologic therapies for low back pain of any duration, according to an updated guideline from the American College of Physicians. For acute and subacute low back pain, first-line choices include heat, massage, acupunct[...]
  • Small-practice telemedicine waits on higher, more consistent reimbursement

    on February 13th, 2017
    We get paid to see patients. So what happens when patients aren’t in the room? This is a big and growing issue in medicine. I do hospital call on weekends, and occasionally have a long meeting with families. In some cases, this involves a large group in a conference room. These meetings can take q[...]
  • Low-back pain: CBT, mindfulness benefits diminish over time

    on February 12th, 2017
    FROM JAMA For patients with chronic low-back pain, the benefits of cognitive-behavioral therapy and mindfulness-based stress reduction that were reported at 6 months and 1 year largely disappeared by 2-year follow-up, according to a Research Letter to the Editor published Feb 14 in JAMA. In a clinic[...]
  • FDA approves Emflaza for Duchenne muscular dystrophy

    on February 9th, 2017
    Emflaza, a tablet and oral suspension corticosteroid, has been approved by the Food and Drug Administration for the treatment of Duchenne muscular dystrophy in patients aged 5 years and older. The agency’s Feb. 9 announcement notes that similar corticosteroids have been used around the world to tr[...]
  • IgG4-related disease can strike any organ system

    on February 9th, 2017
    EXPERT ANALYSIS FROM THE WINTER RHEUMATOLOGY SYMPOSIUM SNOWMASS, COLO. (FRONTLINE MEDICAL NEWS) – Progress in the understanding and treatment of immunoglobulin G4–related disease is occurring “at lightning speed,” John H. Stone, MD, said at the Winter Rheumatology Symposium sponsored by the [...]
Back to top